Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Targeted Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Testing effectiveness (Phase 2)UnknownNCT02969096
What this trial is testing

Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma

Who this might be right for
Liver Neoplasms
Shanghai University of Traditional Chinese Medicine 30
Early research (Phase 1)Looking for participantsNCT07082920
What this trial is testing

JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 140
Testing effectiveness (Phase 2)Study completedNCT00397579
What this trial is testing

DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesBlastic Plasmacytoid Dendritic Cell Neoplasm
University of Texas Southwestern Medical Center 11
Not applicableStudy completedNCT02323555
What this trial is testing

Optimize the Requirements and Preparations in Outpatient Chemotherapy

Who this might be right for
CancerIV Anticancer Therapy
Centre Francois Baclesse 624
Not applicableStudy completedNCT00121485
What this trial is testing

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy

Who this might be right for
Heart Failure, CongestiveVentricular DysfunctionCardiomyopathies
Abbott Medical Devices 200
Not applicableUnknownNCT06358118
What this trial is testing

Buyuan-zhixiao Formula in the Treatment of Elderly Patients With Diabetes and Multiple Metabolic Disorders

Who this might be right for
Diabete MellitusAgingMetabolic Disorders+2 more
Qing Ni 240
Testing effectiveness (Phase 2)Looking for participantsNCT05401097
What this trial is testing

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

Who this might be right for
Acute Myeloid Leukemia
Alice Mims 125
Early research (Phase 1)Not Yet RecruitingNCT07539610
What this trial is testing

Evaluation of the Safety and Efficacy of Sup19 CAR-T Cells in Patients With Previously Failed CD19-Targeted Therapy or CD19-Weakly Expressed Hematologic Tumors

Who this might be right for
B-Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 9
Testing effectiveness (Phase 2)Study completedNCT02362646
What this trial is testing

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients

Who this might be right for
Heart FailureCardiomyopathyVentricular Dysfunction
Annetine Gelijns 159
Large-scale testing (Phase 3)Active Not RecruitingNCT01224288
What this trial is testing

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 120
Not applicableStudy completedNCT00450567
What this trial is testing

Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT04235036
What this trial is testing

Ibrutinib and Rituxan for Chronic GVHD

Who this might be right for
Graft Vs Host Disease
Northside Hospital, Inc. 15
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Early research (Phase 1)Study completedNCT03485963
What this trial is testing

HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals

Who this might be right for
HIV Infections
Catherine Bollard 7
Post-approval studies (Phase 4)UnknownNCT03500367
What this trial is testing

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

Who this might be right for
Uterine Fibroids
Peking Union Medical College Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Not applicableStudy completedNCT04407767
What this trial is testing

A Case Formulation Approach to Cognitive Processing Therapy

Who this might be right for
Posttraumatic Stress Disorder
VA Office of Research and Development 179
Not applicableEnded earlyNCT02963363
What this trial is testing

Adapted Physical Activity for Breast Cancer HER2 Positive Patient

Who this might be right for
HER2 Positive Breast Cancer
Centre Jean Perrin 36
Early research (Phase 1)Study completedNCT02215967
What this trial is testing

Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-Multiple
National Cancer Institute (NCI) 30
Next Page